samedan logo
 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

OMRON halves cost to cobot palletise solving pharma industry’s workforce challenges

Omron Electronics Ltd



Stand B34, PPMA Show 2021, 28-30 September, NEC, Birmingham – Responding to the pharmaceutical industry’s end-of-line labour challenges including staff shortages, social distancing measures and self-isolation, OMRON UK will debut its game changing cobot palletiser, the RB1200, at PPMA Show 2021. Thanks to OMRON’s renowned iAutomation proprietary technology, the cobot system boasts a 50% cost saving, rapid delivery within weeks and plug-and-play system architecture to help pharma manufacturers of all budgets and sizes immediately de-risk their line against today’s unprecedented labour challenges.



The introduction of the RB1200 could not be timelier. Pharmaceutical businesses are navigating social distancing guidelines amid high vacancy rates compounded by Brexit and the long-term skills shortage, putting pressure on existing staff and affecting productivity. Adding to this anxiety is the risk of production being halted entirely due to an on-site Covid outbreak or high numbers of staff self-isolating; events which are outside of a company’s control.

The RB1200 was developed in partnership with OMRON’s automation partner Reeco. Together, the two companies have designed a cobot palletiser that makes pharma manufacturers more resilient to the detrimental effects of both labour shortages and the possibility of immediate workforce interruptions. Using OMRON’s 3i concept of intelligent, integrated and interactive engineering methods has dramatically shortened system design and delivery time resulting in a 50% cost reduction compared to same spec cobot palletisers.



A modular, plug-and-play solution, the RB1200 has a maximum payload of 10kg and a cycle time of 12 picks per minute. It requires no system integration and boasts a 60% smaller footprint than conventional robot palletisers. Its inherent flexibility also means it can easily switch between lines and handle rapid changes in demand, maximising users’ investment.

In addition to its automated palletising solution, OMRON will also showcase the Quattro; the world’s fastest and most flexible Delta pick-and-place robot. With a pick rate of 300 per minute and the only Delta robot to be USDA-certified, the Quattro’s fourth arm allows it to reach up to 30% further than traditional designs, facilitating a larger operational area. The powerful combination of speed, manipulation, reach and a 15kg payload make it ideal for any pharmaceutical packaging application.

For a full demonstration of the RB1200 cobot palletiser or the Quattro pick-and-place robot, visit stand B34 at PPMA Show 2021.
phone 01908 258253
email uk@eu.omron.com
web www.industrial.omron.co.uk
email Opal Drive, Fox Milne, Milton Keynes, MK15 0DG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Biognosys Announces the Launch of its Next-Generation Plasma Biomarker Discovery Solution

October 5th, 2021 – SCHLIEREN, (Zurich, Switzerland). Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, today announces the upcoming launch of its next-generation plasma biomarker discovery solution.
More info >>


White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement